Time to go home after a wonderful event #ESMOBreast24 . It was a pleasure and an honor to be part of the group #ESMOAmbassadors with such brilliant and kind colleagues. 3 days of the highest standards of science but the best was to share it with friends!!! #ESMOYOC
Negative results of Impassion132 of the addition of atezolizumab to chemotherapy in early relapse TNBC presented by Rebecca Dent . So much still needed for this population. #ESMOBreast24 #ESMOAmbassadors
Something for #radiationoncologists at #ESMOSarcomaAndRareCancers24
Is there a płace for intraoperative radiotherapy in retroperitoneal sarcoma?
⬇️check below what are Rick Haas conclusions
ESMO - Eur. Oncology #ESMOAmbassadors
#ELCC24 Charu Aggarwal, MD, MPH, FASCO takes a deep dive on how to implement liquid Bx and #ctDNA in clinical trial design in early-locally advanced #NSCLC focusing on intensify/de-escalate risk-stratified strategies.
#ESMOAmbassadors #some #LCSM
ESMO - Eur. Oncology IASLC
#ESMOBreast24 #ESMOAmbassadors
Prof Philippe Aftimos, MD provided a great overview of the implementation of novel endocrine therapies and combinations in metastatic #breastcancer
ESMO - Eur. Oncology #bcsm OncoAlert
#ESMOBreast24 #ESMOAmbassadors
Prof #SybilleLoibl tackles the exciting and challenging topic of the future of IO in #breastcancer : combinations and beyond
G Curigliano MD PhD Sung-Bae Kim ESMO - Eur. Oncology
German Breast Group #bcsm OncoAlert
Wrap up of the #ESMOSarcomaAndRareCancers24 - Real world data and real world evidence in sarcoma. Valuable insights into methodology and challenges from Herbert Loong and Paul Huang Lab
ESMO - Eur. Oncology #ESMOAmbassadors
#ESMOBreast24
⏰Time for the #ESMOYOC Clinical case discussion 👩⚕️ now ongoing in Frankfurt hall #AnnaLeaAmylidi Eva M Ciruelos
Rodrigo Sánchez-Bayona Pablo Mando Matteo Lambertini, MD PhD Evandro de Azambuja, MD, PhD
ESMO - Eur. Oncology #ESMOAmbassadors #bcsm
Are you attending #ESMOSarcomaAndRareCancers24 ?
Don't miss our excelent Young Oncologists Sessions:
🔸Vesalius talk on managing work-life overload
🔸Clinical case discussion
🔸Mentorship session
William Tap Dario Callegaro Herbert Loong Christoph_Oing
ESMO - Eur. Oncology #ESMOAmbassadors
ctDNA in GIST:
🔸ready to use for mutation testing
🏮not read for disease monitoring or detection of MRD (eg. Deciding on duration of adjuvant imatinib re:Tom Wei-Wu Chen)
Fantastic overview by César Serrano García Vall d'Hebron
#ESMOSarcomaAndRareCancers24 #ESMOAmbassadors ESMO - Eur. Oncology
#ESMOSarcomaAndRareTumors24 starting now!
Robin Lewis Jones and Jean-Yves Blay opening the this unique experience for rare tumors community!
With Silvia Stacchiotti César Serrano García we will try to give some insights for those who could come to Lugano
#ESMOAmbassadors ESMO - Eur. Oncology
#ELCC24 Umberto Malapelle takes us through a fascinating journey on the future of liquid biopsy, emphasising the value of detectability, the robustness of methodology, the DNA➡️mRNA➡️Protein continuum and AI implications
#ESMOAmbassadors , ESMO - Eur. Oncology IASLC
3 or 6 years of adjuvant imatinib in #GIST ?
🔹better DFS for 6 years
🔹need mature OS data
🚨NOT ready for change of clinical praktyce
Great discussion by César Serrano García
#ESMOSarcomaAndRareCancers24 #ESMOAmbassadors ESMO - Eur. Oncology
#ELCC
ADCs: the promising new therapy?
Discussing all things antibody-drug conjugates, join me, #EgbertSmit #IgnatioWistuba & Solange Peters in Forum Hall today at 10am
#ESMOambassadors #ELCC 24 ESMO - Eur. Oncology Beaumont RCSI Cancer Centre RCSI
Very promising activity with PF07220060, a new CDK4i. Among 33 pretreated (median: 4) pts, all with prior CDK4/6i, ORR was 32%, DCR 81%, mPFS 8.1 months, with favorable tox profile. The new generation of CDK inhibitors is here: looking forward to randomized data. #ESMOAmbassadors
#ESMOBreast24 #ESMOAmbassadors
New promising data summarized by Philippe Aftimos, MD on #palazestrant combined with #ribociclib
🔹 #Opera -01 P3 study with #palazestrant is recruiting
🔹ribo combination will be evaluated in an upcoming P3 trial
ESMO - Eur. Oncology #bcsm OncoAlert
#ESMOBreast24
⭐️ Congratulations to Dr. Hope Rugo for being granted the ESMO - Eur. Oncology Breast Cancer Award 🥇 As amazing scientist, caregiver and human being she has a huge impact on the advances in the field and inspires countless colleagues #ESMOAmbassadors #bcsm
#ESMOBreast24 #ESMOAmbassadors
Prof Sung-Bae Kim provides the current status of immunotherapy in #breastcancer beyond #TNBC
Sung-Bae Kim ESMO - Eur. Oncology #bcsm OncoAlert G Curigliano MD PhD German Breast Group #SybilleLoibl
#ESMOBreast24 #ESMOAmbassadors
Prof G Curigliano MD PhD focusses on the current status of immunotherapy in #TNBC
➡️Standard in neoadjuvant and adjuvant for stage 2/3
➡️Important to note different prognostic value of pCR according to stage at diagnosis
ESMO - Eur. Oncology #bcsm
